MedTrace Logo

Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children

NCT00438217 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2007-02-22

No results posted yet for this study

Summary

The goal of CPP-EDG 01 study is to assess possible genetic and/or environmental parameters which may influence the growth rate of children affected by precocious puberty. In this view, we are collecting clinical data and biological samples of children attended as outpatients at the Pediatric Endocrine Center of Pisa from 1998 to present (the study is still open). From biological (blood) samples, gene polymorphisms such as endocrine disruptor levels are determined and compared to different growth pattern of pediatric patients treated with different GnRH agonists.

Conditions

  • Central Precocious Puberty

Interventions

DRUG

Triptorelin (GnRH agonists)

DRUG

Leuprolide (GnRH agonists)

Sponsors & Collaborators

  • University of Pisa

    lead OTHER

Principal Investigators

  • Giuseppe Saggese, MD · Department of Pediatrics, University of Pisa

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00438217 on ClinicalTrials.gov